Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...
Sukhu said that this was possible due to ‘Vayavastha Parivartan’ and smart policies undertaken by the present government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback